Evidence map›Paper›PMID 25385624›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Polyspecific pyrrolysyl-tRNA synthetases from directed evolution.

Li-Tao Guo, Yane-Shih Wang, Akiyoshi Nakamura, Daniel Eiler, Jennifer M Kavran, Margaret Wong, Laura L Kiessling, Thomas A Steitz, Patrick O'Donoghue, Dieter Söll

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Li-Tao GuoDepartments of Molecular Biophysics & Biochemistry and.
Yane-Shih WangDepartments of Molecular Biophysics & Biochemistry and.
Akiyoshi NakamuraDepartments of Molecular Biophysics & Biochemistry and Chemistry, and.
Daniel EilerDepartments of Molecular Biophysics & Biochemistry and.
Jennifer M KavranDepartments of Molecular Biophysics & Biochemistry and.
Margaret WongNovartis Institutes of Biomedical Research, Cambridge, MA 02139;
Laura L KiesslingDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI 53706; and.
Thomas A SteitzDepartments of Molecular Biophysics & Biochemistry and Chemistry, and Howard Hughes Medical Institute, Yale University, New Haven, CT 06510;
Patrick O'DonoghueDepartments of Biochemistry and Chemistry, The University of Western Ontario, London, ON, Canada N6A 5C1 patrick.odonoghue@uwo.ca dieter.soll@yale.edu.
Dieter SöllDepartments of Molecular Biophysics & Biochemistry and Chemistry, and patrick.odonoghue@uwo.ca dieter.soll@yale.edu.

Funding

X-RAY ANALYSIS OF PROTEIN STRUCTURE AND FUNCTIONP01GM022778 · NIGMS · YALE UNIVERSITY · PI BREAKER, RONALD R · 1985 to 2019
$26.1M
TRANSFER RNAR01GM022854 · NIGMS · YALE UNIVERSITY · PI SOLL, DIETER · 1985 to 2016
$21.3M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
MULTIVALENT PROTEIN CARBOHYDRATE INTERACTIONSR01GM055984 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI KIESSLING, LAURA L · 1997 to 2014
$3.9M
TRANSFER RNAR37GM022854 · NIGMS · YALE UNIVERSITY · PI SOLL, DIETER G · 1991 to 2000
$786k
Howard Hughes Medical InstituteNIGMS NIH HHS GM055984NIGMS NIH HHS GM22854NIGMS NIH HHS P01 GM022778NIGMS NIH HHS P41 GM111244NIGMS NIH HHS R01 GM022854NIGMS NIH HHS R01 GM055984NIGMS NIH HHS R37 GM022854
6 · The paper itself

Abstract

Pyrrolysyl-tRNA synthetase (PylRS) and its cognate tRNA(Pyl) have emerged as ideal translation components for genetic code innovation. Variants of the enzyme facilitate the incorporation >100 noncanonical amino acids (ncAAs) into proteins. PylRS variants were previously selected to acylate N(ε)-acetyl-Lys (AcK) onto tRNA(Pyl). Here, we examine an N(ε)-acetyl-lysyl-tRNA synthetase (AcKRS), which is polyspecific (i.e., active with a broad range of ncAAs) and 30-fold more efficient with Phe derivatives than it is with AcK. Structural and biochemical data reveal the molecular basis of polyspecificity in AcKRS and in a PylRS variant [iodo-phenylalanyl-tRNA synthetase (IFRS)] that displays both enhanced activity and substrate promiscuity over a chemical library of 313 ncAAs. IFRS, a product of directed evolution, has distinct binding modes for different ncAAs. These data indicate that in vivo selections do not produce optimally specific tRNA synthetases and suggest that translation fidelity will become an increasingly dominant factor in expanding the genetic code far beyond 20 amino acids.

Indexed as

Directed Molecular EvolutionAmino Acyl-tRNA SynthetasesKineticsLysineAmino Acyl-tRNA SynthetasesLysineaminoacyl-tRNA synthetasegenetic codegenetic selectionposttranslational modificationsynthetic biology

Identifiers

PMID25385624
PMCPMC4250173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.